Oncogenic KrasG12D was shown to stimulate the production of GM-CSF by pancreatic ductal cells, which led to the recruitment of CD8 T-cell-suppressing myeloid cells in vivo and subsequent cancer outgrowth (Pylayeva-Gupta et al, 2012). The gene discussed is CSF2; the disease is cancer.